Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 3 Analysis of primary endpoints (Study B) prior to 4-weeks regular treatment with SFC (50/100 mcg) or FBC (4.5/160 mcg)

From: Inhaled steroid/long-acting β2 agonist combination products provide 24 hours improvement in lung function in adult asthmatic patients

  SFC (n = 74) FBC (n= 69) Statistics SFC-FBC
    Difference (se) 95% CI P value
Slope of decline in FEV 1 (ml/hr) from 2–24 hours post dose      
Adjusted mean (se) -15.97 (1.91) -14.15 (1.98) 1.82 (2.04) -5.88, 2.24 0.375
Area under FEV 1 curve (weighted mean, Lxmin)      
Adjusted mean (se) 0.21 (0.04) 0.22 (0.04) -0.01 (0.04) -0.09, 0.06 0.721
Mean change from pre-dose FEV 1 (L) at 12 hours post dose      
Adjusted baseline mean (se) 2.97 (0.04) 2.96 (0.04) 0.01 (0.04) -0.08, 0.09 0.892
Adjusted mean change (se) 0.21 (0.04) 0.20 (0.04)